Avid Bioservices, Inc. ( CDMO) - Key Metrics
Stock symbol CDMO is outdated, potentially delisted? Maybe it is available on other exchange?
CDMO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q1 | $0.63 | -$0.09 | -$0.06 | -$0.08 |
| 2024Q4 | $0.68 | -$1.94 | $0.02 | -$0.07 |
| 2024Q3 | $0.53 | -$0.09 | $0.06 | -$0.01 |
| 2024Q2 | $0.40 | -$0.15 | $0.10 | -$0.02 |
| 2024Q1 | $0.60 | -$0.03 | $0 | -$0.23 |
CDMO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q1 | ? | -30.01 |
| 2024Q4 | ? | -0.98 |
| 2024Q3 | ? | -17.84 |
| 2024Q2 | ? | -10.21 |
| 2024Q1 | ? | -95.02 |
CDMO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q1 | -0.75% | ? |
| 2024Q4 | -0.92% | ? |
| 2024Q3 | -0.19% | ? |
| 2024Q2 | -0.32% | ? |
| 2024Q1 | -1.81% | ? |
CDMO
Price: $12.49
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.41 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 451500
Ebitda: -12.0 millionMarket Capitalization: 798.9 million